$42.760
-1.385 (-3.24%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EWTX Prediction & Forecast by Similar Chart Analysis
Alphio's EWTX stock price prediction model matches the current Edgewise Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $42.60 (-0.38%). The 1-week path is $41.97 (-1.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Edgewise Therapeutics Inc Stock?
Edgewise Therapeutics Inc (EWTX) is currently not a strong buy due to its recent price decline and negative earnings reports. The current price is $42.76, with a 1-year change of +187.75%, indicating strong past performance but recent volatility. The RSI is at 37.173, suggesting it is nearing oversold territory, which could indicate a potential rebound. However, the company reported a Q2 EPS of -$0.53, which is worse than the estimate of -$0.48, indicating ongoing financial struggles. Additionally, insider selling has increased by 125.90% over the last month, which may signal a lack of confidence among insiders. Therefore, while the long-term outlook may still hold potential due to positive clinical trial data and significant cash reserves, the current technical and sentiment indicators suggest a hold rather than a buy at this moment.
EWTX stock price ended at $42.76 on Friday, after losing -3.24%
Edgewise Therapeutics Inc (EWTX) last closed at $42.76, losing -3.24%. These facts feed the 1-day and 1-week EWTX price prediction above.
Forecast Drivers
Edgewise Therapeutics Inc (EWTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches EWTX, ranked by similarity.
Seasonality analysis for EWTX
Historically the probability of a positive August return for EWTX is 66.67%. February offers the highest probability of a positive month at 77.59%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EWTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $12.02 | $14.67 | $16.60 | -65.69% |
| Sep 2026 | $10.32 | $12.08 | $14.44 | -71.74% |
| Oct 2026 | $15.20 | $16.07 | $18.55 | -62.41% |
| Nov 2026 | $13.83 | $14.59 | $16.62 | -65.88% |
| Dec 2026 | $14.97 | $15.85 | $16.79 | -62.94% |
In 2026, Edgewise Therapeutics Inc (EWTX) is projected to range from $10.32 to $18.55.
Edgewise Therapeutics Inc 2026 monthly forecast
In Aug 2026, Edgewise Therapeutics Inc is projected to average $14.67, with a low of $12.02 and high of $16.60.
In Sep 2026, Edgewise Therapeutics Inc is projected to average $12.08, with a low of $10.32 and high of $14.44.
In Oct 2026, Edgewise Therapeutics Inc is projected to average $16.07, with a low of $15.20 and high of $18.55.
In Nov 2026, Edgewise Therapeutics Inc is projected to average $14.59, with a low of $13.83 and high of $16.62.
In Dec 2026, Edgewise Therapeutics Inc is projected to average $15.85, with a low of $14.97 and high of $16.79.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.